annual EBIT:
$14.65B+$4.67B(+46.78%)Summary
- As of today (April 16, 2025), NVS annual earnings before interest & taxes is $14.65 billion, with the most recent change of +$4.67 billion (+46.78%) on December 31, 2024.
- During the last 3 years, NVS annual EBIT has fallen by -$10.67 billion (-42.15%).
- NVS annual EBIT is now -42.15% below its all-time high of $25.32 billion, reached on December 31, 2021.
Performance
NVS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$3.56B-$89.00M(-2.44%)Summary
- As of today (April 16, 2025), NVS quarterly earnings before interest & taxes is $3.56 billion, with the most recent change of -$89.00 million (-2.44%) on December 31, 2024.
- Over the past year, NVS quarterly EBIT has dropped by -$527.00 million (-12.89%).
- NVS quarterly EBIT is now -77.07% below its all-time high of $15.53 billion, reached on December 31, 2021.
Performance
NVS quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$14.65B+$966.00M(+7.06%)Summary
- As of today (April 16, 2025), NVS TTM earnings before interest & taxes is $14.65 billion, with the most recent change of +$966.00 million (+7.06%) on December 31, 2024.
- Over the past year, NVS TTM EBIT has increased by +$2.84 billion (+24.07%).
- NVS TTM EBIT is now -42.64% below its all-time high of $25.54 billion, reached on March 31, 2022.
Performance
NVS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.8% | -12.9% | +24.1% |
| 3 y3 years | -42.1% | +98.5% | -34.7% |
| 5 y5 years | +49.6% | +42.0% | +47.1% |
NVS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.1% | +83.6% | -12.9% | +100.7% | -42.6% | +71.6% |
| 5 y | 5-year | -42.1% | +83.6% | -77.1% | +100.7% | -42.6% | +71.6% |
| alltime | all time | -42.1% | +217.7% | -77.1% | +132.4% | -42.6% | +939.3% |
Novartis AG EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $14.65B(+46.8%) | $3.56B(-2.4%) | $14.65B(+7.1%) |
| Sep 2024 | - | $3.65B(-10.7%) | $13.68B(+15.9%) |
| Jun 2024 | - | $4.09B(+22.0%) | $11.80B(+11.3%) |
| Mar 2024 | - | $3.35B(+29.1%) | $10.61B(+6.3%) |
| Dec 2023 | $9.98B(+25.1%) | $2.59B(+46.2%) | $9.98B(+8.9%) |
| Sep 2023 | - | $1.77B(-38.6%) | $9.16B(-0.2%) |
| Jun 2023 | - | $2.89B(+6.3%) | $9.18B(+7.6%) |
| Mar 2023 | - | $2.72B(+53.2%) | $8.53B(-1.7%) |
| Dec 2022 | $7.98B(-68.5%) | $1.78B(-0.9%) | $8.68B(-61.3%) |
| Sep 2022 | - | $1.79B(-20.1%) | $22.43B(-6.8%) |
| Jun 2022 | - | $2.24B(-21.8%) | $24.07B(-5.7%) |
| Mar 2022 | - | $2.87B(-81.5%) | $25.54B(+0.9%) |
| Dec 2021 | $25.32B(+135.6%) | $15.53B(+352.4%) | $25.32B(+101.7%) |
| Sep 2021 | - | $3.43B(-7.4%) | $12.55B(+6.9%) |
| Jun 2021 | - | $3.71B(+39.8%) | $11.74B(+11.4%) |
| Mar 2021 | - | $2.65B(-3.9%) | $10.54B(-1.9%) |
| Dec 2020 | $10.75B(+9.8%) | $2.76B(+5.4%) | $10.75B(+8.0%) |
| Sep 2020 | - | $2.62B(+4.4%) | $9.95B(-0.0%) |
| Jun 2020 | - | $2.51B(-12.3%) | $9.95B(-3.2%) |
| Mar 2020 | - | $2.86B(+45.8%) | $10.28B(+5.0%) |
| Dec 2019 | $9.79B(-34.9%) | $1.96B(-25.2%) | $9.79B(+4.0%) |
| Sep 2019 | - | $2.62B(-7.6%) | $9.41B(+1.5%) |
| Jun 2019 | - | $2.84B(+20.0%) | $9.27B(-37.5%) |
| Mar 2019 | - | $2.37B(+49.7%) | $14.84B(-1.3%) |
| Dec 2018 | $15.03B(+52.5%) | $1.58B(-36.3%) | $15.03B(-6.3%) |
| Sep 2018 | - | $2.48B(-70.5%) | $16.03B(-0.9%) |
| Jun 2018 | - | $8.41B(+228.7%) | $16.18B(+57.4%) |
| Mar 2018 | - | $2.56B(-1.0%) | $10.28B(+4.4%) |
| Dec 2017 | $9.85B(+15.6%) | $2.58B(-1.8%) | $9.85B(+15.7%) |
| Sep 2017 | - | $2.63B(+5.0%) | $8.51B(+2.2%) |
| Jun 2017 | - | $2.51B(+17.9%) | $8.33B(+2.6%) |
| Mar 2017 | - | $2.13B(+70.7%) | $8.11B(-4.8%) |
| Dec 2016 | $8.52B(-3.0%) | $1.25B(-49.1%) | $8.52B(-0.5%) |
| Sep 2016 | - | $2.45B(+6.8%) | $8.57B(+1.5%) |
| Jun 2016 | - | $2.29B(-9.6%) | $8.44B(-0.3%) |
| Mar 2016 | - | $2.54B(+96.8%) | $8.47B(-3.6%) |
| Dec 2015 | $8.79B(-32.3%) | $1.29B(-44.5%) | $8.79B(-15.8%) |
| Sep 2015 | - | $2.32B(+0.1%) | $10.44B(-11.8%) |
| Jun 2015 | - | $2.32B(-18.8%) | $11.84B(-7.7%) |
| Mar 2015 | - | $2.86B(-3.0%) | $12.83B(-1.1%) |
| Dec 2014 | $12.98B(+12.9%) | $2.94B(-20.7%) | $12.98B(+4.0%) |
| Sep 2014 | - | $3.71B(+12.1%) | $12.48B(+9.2%) |
| Jun 2014 | - | $3.31B(+10.2%) | $11.42B(+0.9%) |
| Mar 2014 | - | $3.00B(+22.9%) | $11.32B(-0.1%) |
| Dec 2013 | $11.49B(-3.9%) | $2.45B(-8.0%) | $11.33B(-3.5%) |
| Sep 2013 | - | $2.66B(-17.2%) | $11.74B(-2.5%) |
| Jun 2013 | - | $3.21B(+6.5%) | $12.04B(-0.9%) |
| Mar 2013 | - | $3.01B(+5.4%) | $12.15B(+1.6%) |
| Dec 2012 | $11.96B | $2.86B(-3.3%) | $11.96B(+15.9%) |
| Sep 2012 | - | $2.96B(-10.8%) | $10.32B(-1.4%) |
| Jun 2012 | - | $3.32B(+17.5%) | $10.46B(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $2.82B(+132.0%) | $10.58B(-6.4%) |
| Dec 2011 | $11.31B(-8.8%) | $1.22B(-60.8%) | $11.31B(-11.0%) |
| Sep 2011 | - | $3.11B(-9.6%) | $12.71B(+1.0%) |
| Jun 2011 | - | $3.44B(-3.1%) | $12.58B(+2.5%) |
| Mar 2011 | - | $3.55B(+35.6%) | $12.28B(-0.9%) |
| Dec 2010 | $12.39B(+18.3%) | $2.62B(-12.3%) | $12.39B(-1.8%) |
| Sep 2010 | - | $2.98B(-4.8%) | $12.63B(+2.6%) |
| Jun 2010 | - | $3.13B(-14.5%) | $12.31B(+4.7%) |
| Mar 2010 | - | $3.66B(+28.6%) | $11.75B(+12.2%) |
| Dec 2009 | $10.47B(+7.0%) | $2.85B(+6.9%) | $10.47B(+10.7%) |
| Sep 2009 | - | $2.66B(+3.3%) | $9.46B(+1.6%) |
| Jun 2009 | - | $2.58B(+8.3%) | $9.31B(-0.9%) |
| Mar 2009 | - | $2.38B(+29.8%) | $9.40B(-1.1%) |
| Dec 2008 | $9.79B(+26.7%) | $1.83B(-27.1%) | $9.50B(+6.6%) |
| Sep 2008 | - | $2.52B(-5.6%) | $8.92B(+5.6%) |
| Jun 2008 | - | $2.67B(+7.1%) | $8.45B(+7.9%) |
| Mar 2008 | - | $2.49B(+99.0%) | $7.83B(+2.0%) |
| Dec 2007 | $7.72B(-6.5%) | $1.25B(-38.8%) | $7.67B(-12.5%) |
| Sep 2007 | - | $2.04B(-0.1%) | $8.77B(+0.7%) |
| Jun 2007 | - | $2.04B(-12.4%) | $8.70B(-0.2%) |
| Mar 2007 | - | $2.33B(-0.3%) | $8.72B(+3.3%) |
| Dec 2006 | $8.26B(+15.3%) | $2.34B(+18.4%) | $8.45B(+7.6%) |
| Sep 2006 | - | $1.98B(-4.2%) | $7.85B(+1.2%) |
| Jun 2006 | - | $2.06B(+0.3%) | $7.75B(+2.9%) |
| Mar 2006 | - | $2.06B(+18.0%) | $7.54B(+5.3%) |
| Dec 2005 | $7.16B(+7.3%) | $1.74B(-7.6%) | $7.16B(+1.1%) |
| Sep 2005 | - | $1.89B(+2.1%) | $7.08B(+2.5%) |
| Jun 2005 | - | $1.85B(+10.1%) | $6.91B(+0.8%) |
| Mar 2005 | - | $1.68B(+0.8%) | $6.86B(+2.8%) |
| Dec 2004 | $6.67B(+11.6%) | $1.67B(-3.0%) | $6.67B(-0.4%) |
| Sep 2004 | - | $1.72B(-4.3%) | $6.70B(+3.8%) |
| Jun 2004 | - | $1.79B(+20.1%) | $6.45B(+5.4%) |
| Mar 2004 | - | $1.49B(-11.8%) | $6.12B(+2.4%) |
| Dec 2003 | $5.98B(+1.4%) | $1.69B(+15.3%) | $5.98B(-7.0%) |
| Sep 2003 | - | $1.47B(+0.4%) | $6.43B(+3.7%) |
| Jun 2003 | - | $1.46B(+8.3%) | $6.20B(+0.3%) |
| Mar 2003 | - | $1.35B(-37.0%) | $6.18B(-36.2%) |
| Dec 2002 | $5.89B(+20.0%) | $2.15B(+72.8%) | $9.69B(-655.2%) |
| Sep 2002 | - | $1.24B(-13.9%) | -$1.75B(-167.4%) |
| Jun 2002 | - | $1.44B(-70.3%) | $2.59B(+22.2%) |
| Mar 2002 | - | $4.86B(-152.3%) | $2.12B(+24.6%) |
| Dec 2001 | $4.91B(+0.5%) | -$9.29B(-266.6%) | $1.70B(>+9900.0%) |
| Sep 2001 | - | $5.58B(+474.3%) | $0.00(-100.0%) |
| Jun 2001 | - | $971.00M(-78.1%) | -$695.00M(+4.4%) |
| Mar 2001 | - | $4.44B(-140.4%) | -$666.00M(-212.7%) |
| Dec 2000 | $4.88B(+5.9%) | -$10.99B(-325.1%) | $591.00M(-94.9%) |
| Sep 2000 | - | $4.88B(+388.1%) | $11.58B(+72.9%) |
| Jun 2000 | - | $1.00B(-82.4%) | $6.70B(+17.6%) |
| Mar 2000 | - | $5.70B | $5.70B |
| Dec 1999 | $4.61B(-8.3%) | - | - |
| Dec 1998 | $5.03B | - | - |
FAQ
- What is Novartis AG annual earnings before interest & taxes?
- What is the all time high annual EBIT for Novartis AG?
- What is Novartis AG annual EBIT year-on-year change?
- What is Novartis AG quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Novartis AG?
- What is Novartis AG quarterly EBIT year-on-year change?
- What is Novartis AG TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Novartis AG?
- What is Novartis AG TTM EBIT year-on-year change?
What is Novartis AG annual earnings before interest & taxes?
The current annual EBIT of NVS is $14.65B
What is the all time high annual EBIT for Novartis AG?
Novartis AG all-time high annual earnings before interest & taxes is $25.32B
What is Novartis AG annual EBIT year-on-year change?
Over the past year, NVS annual earnings before interest & taxes has changed by +$4.67B (+46.78%)
What is Novartis AG quarterly earnings before interest & taxes?
The current quarterly EBIT of NVS is $3.56B
What is the all time high quarterly EBIT for Novartis AG?
Novartis AG all-time high quarterly earnings before interest & taxes is $15.53B
What is Novartis AG quarterly EBIT year-on-year change?
Over the past year, NVS quarterly earnings before interest & taxes has changed by -$527.00M (-12.89%)
What is Novartis AG TTM earnings before interest & taxes?
The current TTM EBIT of NVS is $14.65B
What is the all time high TTM EBIT for Novartis AG?
Novartis AG all-time high TTM earnings before interest & taxes is $25.54B
What is Novartis AG TTM EBIT year-on-year change?
Over the past year, NVS TTM earnings before interest & taxes has changed by +$2.84B (+24.07%)